Christine Penner

On Friday, May 4, 2018, I went to the Health Sciences Centre to meet with Dr. Pitz. We were looking at the possibility of enrolling in a second brain cancer research study. When we met with the research nurse that afternoon she informed me that I was accepted to take part in the Orbus Stellar research study. I was thrilled and grateful that this time round I was part of the group taking the research study drug.   I started taking the liquid drug Eflornithine on that day. This liquid drug had to be taken every eight hours. I made a schedule and set my iPhone alarm for 6:00 a.m., 2:00 p.m., and 10:00 p.m. to remind me to take my new medication. On Friday, May 18, after two weeks of taking Eflornithine, I took a strong chemo drug in the evening before going to bed. To help combat the side effects of the chemo drugs, I took anti-nausea pills for three days which were very effective. Going forward, I will be taking this chemo drug every six weeks. I felt good and was grateful that I wa